is the compounded tirzepatide safe How to Know If Compound

Many patients continue treatment through a maintenance phase to prevent weight regain and support metabolic health markers

Cardiovascular outcomes GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in large outcome trials

Wegovy carries FDA approval for chronic weight management in adults with a BMI 30, or 27 with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, sleep apnea)

difficile) Avoid colonoscopy in toxic megacolon Management Induction of remission: Mildmoderate: 5-ASA (oral rectal) Moderatesevere: Corticosteroids Severe/refractory: Biologics (anti-TNF, anti-integrin, JAK inhibitors) Maintenance: 5-ASA Azathioprine / biologics (if steroid-dependent) Complications Toxic megacolon Severe bleeding Perforation Colorectal cancer (risk with duration & extent) Surgical Indications Refractory disease Dysplasia or carcinoma Toxic megacolon Massive hemorrhage Colectomy is curative Continuous disease, rectum always involved Limited to mucosa Associated with PSC Smoking appears protective (opposite of Crohns) To view or add a comment, sign in Systemic Lupus Erythematosus (SLE) Definition: SLE is a chronic autoimmune disease in which the immune system attacks multiple organ systems, causing inflammation and tissue damage

The Science of Dual-Agonist Therapy: GLP-1 and GIP Explained Understanding the biological mechanism of Tirzepatide is key to appreciating why it has become such a breakthrough in modern medicine

About 18 percent of respondents said their sexual desire increased after starting medication, while 16 percent said it decreased